zimberelimab Report issue

Biologics mAb Experimental

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: Cc1c(C#N)cccc1-c1cc(-c2cn(Cc3cccc(C(C)(C)O)n3)nn2)nc(N)n1
  • InChIKey: BUXIAWLTBSXYSW-UHFFFAOYSA-N
  • Mol. Mass: 426.48
  • ALogP: 2.84
  • ChEMBL Molecules:
    zimberelimab  
    etrumadenant  
More Chemistry

Pharmacology

Organizations (31)

Research & Development (31)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (42)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (42)


 

Adenocarcinoma (Phase 3)

Bile Duct Neoplasms (Phase 2)

Biliary Tract Neoplasms (Phase 2)

Breast Neoplasms (Phase 1)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma, Merkel Cell (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Renal Cell (Phase 1)

Carcinoma, Transitional Cell (Phase 2)

Cholangiocarcinoma (Phase 2)

Colorectal Neoplasms (Phase 1/Phase 2)

Endometrial Neoplasms (Phase 1)

Esophageal Neoplasms (Phase 1)

Glioblastoma (Early Phase 1)

Head and Neck Neoplasms (Phase 1)

Healthy Volunteers (Phase 1)

Laryngeal Neoplasms (Phase 1)

Liposarcoma (Phase 2)

Liver Neoplasms (Phase 2)

Lung Neoplasms (Phase 3)

Lymphoma (Phase 1)

Lymphoma, Large-Cell, Immunoblastic (Phase 1)

Lymphoma, Non-Hodgkin (Phase 1)

Melanoma (Phase 2)

Mouth Neoplasms (Phase 1)

Multiple Myeloma (Phase 1)

Mutation (Phase 1)

Neoplasms (Phase 2)

Oropharyngeal Neoplasms (Phase 1)

Ovarian Neoplasms (Phase 1/Phase 2)

Pancreatic Neoplasms (Phase 2)

Pharyngeal Neoplasms (Phase 1)

Prostatic Neoplasms (Phase 2)

Prostatic Neoplasms, Castration-Resistant (Phase 2)

Rectal Neoplasms (Phase 2)

Sarcoma (Phase 2)

Small Cell Lung Carcinoma (Phase 3)

Squamous Cell Carcinoma of Head and Neck (Phase 1)

Stomach Neoplasms (Phase 1)

Triple Negative Breast Neoplasms (Phase 2)

Urinary Bladder Neoplasms (Phase 1)

Uterine Cervical Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 51
  • # of Trial Organizations: 31

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue